Oxcarbazepine

CHEMBL1068 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
252.3 g/mol
LogP
1.7
Phase
4

An anticonvulsant for partial seizures and bipolar disorder with generally better tolerability than carbamazepine.

Masse moléculaire

252,2700 g/mol

LogP

1,70

TPSA

63,40 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)N1c2ccccc2CC(=O)c2ccccc21

InChI

InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)

Molecular Formula

C15H12N2O2

HBD / HBA

1 / 2

Liaisons Rotatives

0

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An anticonvulsant for partial seizures and bipolar disorder with generally better tolerability than carbamazepine.

Yes, Oxcarbazepine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1068. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 34312. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.